几种检测膀胱癌的新方法

　　12，Carpinito G A, Stadler W M, Briggman J V. Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract. J Urol,1996,156:1280～1285

　　13，Stampfer D S, Carpinito G A, Rodriguez-Villaneuva J. Evaluation of NMP22 in the detection of recurrent transtional cell carcinoma of the bladder. J Urol,1996,156:1280～1285

　　14，Miyanaga N, Akaza H, Ishikawa S. Clinical evaluation of nuclear matrix protein 22 ( NMP22) in urine as a novel marker for urothelial cancer. Eur Urol,1997,31:163～168

　　15，Schmeter B S, Habicht K K, Lamm D L.A multicenter trial evaluation of the AuraTek FDP test for detection and monitoring of bladder cancer. J Urol,1997,158:801～805

　　16，Bonner R B, Hemstreet G P, Fradet Y. Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells. Cancer,1993,72:2461～2469

　　17，Grossman H B, Washington R W,Carey T E. Alterations in antigen

 
[1] [2] [3] [4] [5] [6] [7] [8] [9]